BRIEF-Galapagos announces $50m extension to AbbVie deal

BRUSSELS Fri May 17, 2013 1:19am EDT

BRUSSELS May 17 (Reuters) - Galapagos NV : * AbbVie and Galapagos extend GLPG0634 collaboration to include crohn's disease * Says AbbVie to pay Galapagos $50 million upon successful completion, expected

in 2015

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.